ANTIDEPRESSANTS: Tell All Book: “Side Effects: Death”: by Former Lilly Exec

Paragraphs two & three read:  “Many of the
horrific school, workplace and mass shootings that have plagued parts of the
world over the years
may not have occurred if the pharmaceutical
industry had been completely honest about the side effects of psychotropic
medication, according to the new book Side Effects: Death – Confessions of a
Pharma Insider
by former executive director of the Swedish Branch of Eli

Lilly & Company John Virapen.”

“Virapen claims that
anti-depressants and selective serotonin reuptake inhibitors
(SSRIs
) were known to have suicidal and homicidal side effects, even during
clinical trials.
Thanks to spin marketing and paid, positive articles in
scientific journals, he points out, the adverse reactions were often ignored or
given little thought by prescribing physicians and patients.”

http://www.prlog.org/10514103-what-big-pharma-knows-sideeffectsdeath.html

What Big Pharma Knows – “Side Effects: Death

Former pharmaceutical executive director reveals industry
secrets

FOR IMMEDIATE RELEASE
PR Log (Press
Release)
Feb 01, 2010 – P.O. Box 9949, College Station, TX.
77842 • Phone/Fax: 877-376-4955
http://www.virtualbookworm.cominfo@virtualbookworm.com

FOR IMMEDIATE RELEASE
Contact: Virtualbookworm.com Publishing Inc.

877-376-4955
reviews@virtualbookworm.com

What Big Pharma
Knows – “Side Effects: Death

Many of the horrific school, workplace and
mass shootings that have plagued parts of the world over the years may not have
occurred if the pharmaceutical industry had been completely honest about the
side effects of psychotropic medication, according to the new book Side Effects:

Death – Confessions of a Pharma Insider by former executive director of the
Swedish Branch of Eli Lilly & Company John Virapen.

Virapen claims
that anti-depressants and selective serotonin reuptake inhibitors (SSRIs) were
known to have suicidal and homicidal side effects, even during clinical trials.
Thanks to spin marketing and paid, positive articles in scientific journals, he
points out, the adverse reactions were often ignored or given little thought by

prescribing physicians and patients.

Virapen also asserts the
pharmaceutical industry has engaged in bribery and other major forms of
corruption to gain approval for and in the marketing of many drugs used to treat
such conditions as Attention Deficit Hyperactivity Disorder (ADHD),
schizophrenia, arthritis, pain, diabetes and many others. The industry also
“makes up” illnesses to enhance sales and market shares, he says.

To
boost sales, Virapen writes, large pharmaceutical corporations spend about
$35,000–$40,000 per year and per practicing doctor to persuade them to prescribe
their products. In addition to covering or “massaging” the negative effects of
drugs, many of the companies engage in “off-label marketing,” which encourages
physicians to prescribe the medicines for conditions for which they haven’t been
approved, Virapen reveals.

Born in British Guyana, John Virapen went
from a door-to-door conman to a pop star, to a pharmaceutical representative to
executive director of one of the largest drug companies in the world. He admits
to participating in bribery, false information and deception to help launch and
market some of the most popularly prescribed (and most dangerous) drugs. In an
effort to exorcise his demons and expose the tactics and dangers of the
pharmaceutical industry, he wrote this expose.

The book has been
published in four languages around the world and is a best-seller in Europe.

Side Effects: Death – Confessions of a Pharma Insider is available in
softcover (ISBN 978-1-60264-516-5) and e-book (ISBN 978-1-60264-517-2) hardcover
from Virtualbookworm.com, Amazon.com, and Barnesandnoble.com. This book can also
be ordered from most bookstores around the United States and United Kingdom.
More information can be found at the book’s official website, www.sideeffectsdeath.com.



De inhoud van dit bericht is vertrouwelijk en alleen bestemd voor de
geadresseerde(n). Anderen dan de geadresseerde(n) mogen geen gebruik maken van
dit bericht, het niet openbaar maken of op enige wijze verspreiden of
vermenigvuldigen. Het UMCG kan niet aansprakelijk gesteld worden voor een
incomplete aankomst of vertraging van dit verzonden bericht.

The contents
of this message are confidential and only intended for the eyes of the
addressee(s). Others than the addressee(s) are not allowed to use this message,
to make it public or to distribute or multiply this message in any way. The UMCG
cannot be held responsible for incomplete reception or delay of this transferred
message.

542 total views, no views today

CYMBALTA: Five Patients Commit Suicide During Clinical Trials: U.S.A.

NOTE FROM Ann Blake-Tracy (www.drugawareness.org):
So even though 19 year old bible college student, Tracy Johnson’s, suicide was the only one we heard about happening in the clinical trials with Cymbalta (taking place within Lilly’s own laboratory in a “healthy volunteer”), there were apparently FOUR MORE SUICIDES in the clinical trials?!!
Paragraphs five &  six read: “While people say many of Cymbalta’s side effects are manageable, some users experience effects that are extremely frightening and potentially dangerous. Some patients found the drug tends to trigger heart palpitations and increase anxiety levels and elevate the severity suicidal thoughts or impulses.”

“A 19-year-old college student who had shown no outward signs of depression killed herself at an Eli Lilly & Company laboratory in Indianapolis where she had been participating in a company drug trial for the experimental antidepressant. Four other patients who were given the drug during earlier trials also committed suicide.”

ADDITIONAL COMMENT BY Ann Blake-Tracy: HOW LONG ARE THEY GOING TO BEAT THIS RIDICULOUS HYPOTHESIS TO DEATH WHEN THERE IS ABSOLUTELY NO EVIDENCE, NOR HAS THERE EVER BEEN, THAT THE SSRI ANTIDEPRESSANTS DO THIS AND MOST ESPECIALLY THERE IS NO EVIDENCE THAT THEY “RESTORE BALANCE TO THE EMOTIONS”??????!!!!!!

I QUOTE ONCE AGAIN THE NEVER ENDING SEROTONIN LIE: “The drug works by preventing serotonin and noradrenaline from being reabsorbed back into the nerve cells in the brain. This helps prolong the mood-lightening effect of any released serotonin and noradrenaline, restoring balance to the emotions of the patient.”

http://www.emaxhealth.com/1357/25/33042/cymbalta-side-effects.html

Submitted by Tyler Woods Ph.D. on Aug 22nd, 2009
Posted under:

Cymbalta, generic name Duloxetine Hydrochloride, has certain side effects consumers should be aware of.

Cymbalta manufactured by Eli Lilly is a serotonin norepinephrine reuptake inhibitor (SNRI) antidepressant used to treat major depression. It is prescribed to treat pain associated with diabetic peripheral neuropathy, which is a painful nerve disorder associated with diabetes that affects the hands, legs, and feet. Cymbalta has only recently been approved for use to treat fibromyalgia if people can tolerate Cymbalta’s side effects.

The drug works by preventing serotonin and noradrenaline from being reabsorbed back into the nerve cells in the brain. This helps prolong the mood-lightening effect of any released serotonin and noradrenaline, restoring balance to the emotions of the patient. Cymbalta may also be used in the treatment of generalized anxiety disorder.

Among the more common Cymbalta side effects that users complain about is being fatigued even after a good night’s sleep. Blurred vision, dry mouth, nausea, vomiting, and issues with both constipation and diarrhea, agitation, irritability, increased, hostility, high blood pressure, decreased libido, hot flashes, fatigue, rash, and increased sweating have also been reported.

While people say many of Cymbalta’s side effects are manageable, some users experience effects that are extremely frightening and potentially dangerous. Some patients found the drug tends to trigger heart palpitations and increase anxiety levels and elevate the severity suicidal thoughts or impulses.

A 19-year-old college student who had shown no outward signs of depression killed herself at an Eli Lilly & Company laboratory in Indianapolis where she had been participating in a company drug trial for the experimental antidepressant. Four other patients who were given the drug during earlier trials also committed suicide.

Anyone taking Cymbalta should understand that they can be at risk while driving, handling machines, or performing other hazardous activities such as working on tall ladders as it can cause dizziness or drowsiness.

Many people report that there were no Cymbalta side effects except for a lowered sexual drive and feel the drug gave them back their life. Like other antidepressants, Cymbalta should not be stopped suddenly if you have been on it for some time. Your brain receptors will adjust to it, and suddenly stopping can cause crying jags, agitation, dizziness, nausea, or headache. You should always talk with your doctor or healthcare provider to work out a plan to slowly decrease your medication to avoid withdrawal symptoms.

People are encouraged to report negative side effects of prescription drugs to the FDA. Visit

www.fda.gov/medwatch, or call 1-800-FDA-1088.

References
New York Times
Drugs.com
Source:
Tyler Woods Ph.D.

603 total views, no views today